Search News Releases

UCLA Health is one of only ten clinical centers nationwide to receive designation as a Clinical Center by the Alliance to Cure Cavernous Malformation for the treatment of cerebral cavernous malformations (CCM).

Researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have received more than $6.8 million in grants from the California Institute for Regenerative Medicine, the state’s stem cell agency, to help develop new stem cell-based technologies to improve patient care.

UCLA Mattel Children’s Hospital ranked in California’s top 5 and once again was recognized for broad excellence in a widely watched assessment of pediatric care.

Dr. Thomas Rando, director of the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA, has received the NOMIS Foundation’s Distinguished Scientist and Scholar Award.

UCLA Health has received the Mitral Valve Repair Reference Center Award from the American Heart Association and the Mitral Foundation for a demonstrated record of superior clinical outcomes resulting from evidence-based, guideline-directed care and high volume in mitral valve repair for degenerative mitral valve regurgitation.  

Dr. Cristina Puig Saus and Dr. Gatien Moriceau, UCLA Jonsson Comprehensive Cancer Center researchers, have received the Young Investigator Award from the Melanoma Research Alliance, the largest nonprofit funder of melanoma research.

Dr. Zhentao Yang and Dr. Yujue Wang, UCLA Jonsson Comprehensive Cancer Center researchers, have been chosen as dermatology fellows by the Melanoma Research Alliance, the largest nonprofit funder of melanoma research. The year-long fellowship provides funding to promising clinicians and researchers-in-training to help advance research in melanoma prevention and early detection.

New research indicates the novel gene editing technique base editing could be used as a one-time therapy to restore the production of T cells in patients born with the rare genetic immune disorder CD3 delta severe combined immunodeficiency.

The UCLA Center for SMART Health, an interdisciplinary collaborative that looks to the integrated transformation of healthcare through emergent data and technologies, and Hearst Health, a division of Hearst and leader in care guidance, today announced the call for submissions is open for the 2022 Hearst Health Prize, a $100,000 award given in recognition of excellence in data science for managing or improving health in the U.S. In addition, up to two finalists will each receive $25,000.

E. Dale Abel, MD, PhD, the William S. Adams Distinguished Professor of Medicine, Chair and Executive Medical Director of the Department of Medicine at the David Geffen School of Medicine and UCLA Health, has been elected to the National Academy of Sciences in recognition of his distinguished achievements and contributions to endocrinology and cardiology.

Dr. Patricia Ganz, UCLA distinguished professor of health policy and management, has been elected a fellow of the Philadelphia-based American Association for Cancer Research Academy.

Four UCLA physicians have been elected to the Association of American Physicians, an honor given to no more than 70 physicians per year. The UCLA physicians elected in 2022 are: neurologist Timothy F. Cloughesy, MD; infectious disease specialist Judith S. Currier, MD, MSc; primary care physician Carol M. Mangione, MD, MSc.; and cardiologist Kalyanam Shivkumar, MD, PhD.

Dr. Daniel Geschwind, a pioneer in the application of systems biology methods in neurologic and psychiatric disease, has been awarded the American Academy of Neurology’s 2022 Cotzias Lecture and Award, the group’s highest honor.

Reflecting broad excellence, the David Geffen School of Medicine at UCLA ranked among the nation’s top 20 medical schools in research and primary care in an annual assessment.

UCLA Health received a perfect score and the designation of “LGBTQ+ Healthcare Equality Leader” in the Human Rights Campaign Foundation’s Healthcare Equality Index (HEI). 

A potential new treatment for glioblastoma that recently received approval for clinical trials not only was developed by three UCLA faculty members but also traces its roots back to 2005, when one of the researchers was a UCLA graduate student.

After two years during which Match Day ceremonies were held virtually due to the pandemic, the David Geffen School of Medicine at UCLA held the event in person on March 18 — and it was bigger and better than ever. 

In a new report, researchers say the challenges of treating long COVID are amplified by a critical issue: we do not know what constitutes long COVID or how to formally diagnose it, an issue that is further exacerbated by limited research data of varying quality and consistency.